STOCK TITAN

Alpine Immune Sciences Announces Company Presentation and Update on AACR Investor Event

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Alpine Immune Sciences will host a virtual investor event on April 12th, 2022, at 6:30 p.m. ET, coinciding with the AACR Annual Meeting. The event time has changed from its original schedule. Additionally, the company will present at the 21st Annual Needham Virtual Healthcare Conference on April 13th at 1:30 p.m. ET. Both events will be available via live webcast and can be replayed for 90 days after the presentations. For more details, visit the Alpine Immune Sciences investor relations website.

Positive
  • None.
Negative
  • None.

- AACR Investor Event time change to 6:30 p.m. ET -

- 21st Annual Needham Virtual Healthcare Conference Presentation April 13th at 1:30 p.m. ET -

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (Nasdaq: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced the company will participate in a company presentation at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13th, 2022, at 1:30 p.m. ET/10:30 a.m. PT.

Alpine will host a virtual investor event on April 12th, 2022, at 6:30 p.m. ET, to coincide with the 2022 American Association for Cancer Research (AACR) Annual Meeting. The meeting will commence 30 minutes later than previously announced and will begin at 6:30 p.m. ET.

A live webcast of both events will be available online in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. A replay of each presentation will be available on the company website for 90 days following the webcast.

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

Investor Relations

Alex Sharif

Director, Investor Relations and Corporate Development

Alpine Immune Sciences, Inc

206-788-4545

ir@alpineimmunesciences.com

Media Relations

Kelli Perkins

Red House

kelli@redhousecomms.com

Source: Alpine Immune Sciences Inc.

FAQ

What is the new time for the AACR investor event by ALPN?

The AACR investor event will now take place on April 12th, 2022, at 6:30 p.m. ET.

When is ALPN presenting at the Needham Virtual Healthcare Conference?

Alpine Immune Sciences will present at the Needham Virtual Healthcare Conference on April 13th, 2022, at 1:30 p.m. ET.

Where can I watch the ALPN investor events?

Both the AACR investor event and the Needham conference presentation can be viewed via live webcast on the Alpine Immune Sciences investor relations website.

Alpine Immune Sciences, Inc.

NASDAQ:ALPN

ALPN Rankings

ALPN Latest News

ALPN Stock Data

4.46B
68.60M
4.65%
99.47%
5.93%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SEATTLE